These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 7161773)
1. Serum beta-endorphin in rheumatic disorders. Denko CW; Aponte J; Gabriel P; Petricevic M J Rheumatol; 1982; 9(6):827-33. PubMed ID: 7161773 [TBL] [Abstract][Full Text] [Related]
2. [Uric acid levels of the serum of healthy persons and patients with various rheumatic diseases]. Bośmanský K; Ondrasík M Ter Arkh; 1987; 59(4):22-5. PubMed ID: 3495897 [TBL] [Abstract][Full Text] [Related]
3. Serum beta-endorphin in primary fibromyalgia syndrome: a controlled study. Yunus MB; Denko CW; Masi AT J Rheumatol; 1986 Feb; 13(1):183-6. PubMed ID: 2939238 [TBL] [Abstract][Full Text] [Related]
7. [Demonstration of increased influenza-A-antibody levels in the serum of patients with chronic polyarthritis]. Wruck K; Zöller B; Faust-Tinnefeldt G; Engel HJ Z Rheumatol; 1985; 44(6):259-62. PubMed ID: 4096127 [TBL] [Abstract][Full Text] [Related]
8. Subsequent risk of hospitalization for neuropsychiatric disorders in patients with rheumatic diseases: a nationwide study from Sweden. Sundquist K; Li X; Hemminki K; Sundquist J Arch Gen Psychiatry; 2008 May; 65(5):501-7. PubMed ID: 18458201 [TBL] [Abstract][Full Text] [Related]
9. Sugar printing rheumatic diseases: a potential method for disease differentiation using immunoglobulin G oligosaccharides. Watson M; Rudd PM; Bland M; Dwek RA; Axford JS Arthritis Rheum; 1999 Aug; 42(8):1682-90. PubMed ID: 10446868 [TBL] [Abstract][Full Text] [Related]
10. Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers. Keyszer G; Lambiri I; Nagel R; Keysser C; Keysser M; Gromnica-Ihle E; Franz J; Burmester GR; Jung K J Rheumatol; 1999 Feb; 26(2):251-8. PubMed ID: 9972954 [TBL] [Abstract][Full Text] [Related]
11. [Serum uric acid levels in disorders of the rheumatic type]. Bosmanský K; Trnavský K Z Rheumatol; 1984; 43(2):59-62. PubMed ID: 6610259 [TBL] [Abstract][Full Text] [Related]
12. [The content of interleukin-1 beta in the blood serum of patients with systemic lupus erythematosus and rheumatoid arthritis]. Ketlinskiĭ SA; Alekseeva TG; Perumov ND; Simbirtsev AS Ter Arkh; 1993; 65(12):51-4. PubMed ID: 8146772 [TBL] [Abstract][Full Text] [Related]
13. Role of the growth hormone/insulin-like growth factor-1 paracrine axis in rheumatic diseases. Denko CW; Malemud CJ Semin Arthritis Rheum; 2005 Aug; 35(1):24-34. PubMed ID: 16084221 [TBL] [Abstract][Full Text] [Related]
18. [The level of the tumor necrosis factor in the blood serum of patients with systemic lupus erythematosus and rheumatoid arthritis]. Prokop'ev AA; Alekseeva TG; Zimina ZV; Ketlinskiĭ SA Ter Arkh; 1993; 65(5):9-12. PubMed ID: 8036608 [TBL] [Abstract][Full Text] [Related]
19. beta-Endorphin, immunological and biochemical changes in synovial fluid in rheumatic disorders. Denko CW; Aponte J; Gabriel P; Petricevic M Clin Rheumatol; 1986 Jan; 5(1):25-32. PubMed ID: 2937602 [TBL] [Abstract][Full Text] [Related]
20. Raised serum vascular endothelial growth factor levels are associated with destructive change in inflammatory arthritis. Ballara S; Taylor PC; Reusch P; Marmé D; Feldmann M; Maini RN; Paleolog EM Arthritis Rheum; 2001 Sep; 44(9):2055-64. PubMed ID: 11592367 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]